The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://jaydorn458692.wikimillions.com/4456834/glp_3_receptor_agonists_retatrutide_trizepatide